Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Broader Horizons For Advanced Biotech In 2022: New Targets, Settings For IO, Cell And Gene Therapy

Feb 01 2022

• By Bridget Silverman

biotech horizon — • Source: Alamy

Related Content

Gene Therapy: AAV Doses Should Not Be Subject To Fixed Upper Limit, US FDA Panel Says

Sep 09 2021

Bluebird Bio Decision in Europe Is A Wake-Up Call For Payers and Industry

Aug 30 2021

US FDA’s Foreign Data Policy Faces Its Greatest Test From Chinese PD-1/L1 Inhibitors

Dec 16 2021

Rx For Immuno-Oncology Excess? Top US FDA Cancer Officials Take On Development ‘Wild West’

Dec 16 2021

BioMarin Gears Up To Give Roctavian Another Go

Jan 13 2022

BMS’s Anti-LAG3 Drug Could Offer Safer Combo Partner To Opdivo Monotherapy Patients

May 20 2021

Bluebird Exits Europe, Casting Clouds Over Gene Therapy Commercial Effort

Aug 09 2021

Roche Gives The Stage To A New Generation Of Cancer Drugs

Sep 15 2021

Bluebird Confident Beti-Cel Will Fare Better In US Than Europe

Dec 14 2021

Janssen/Legend’s Cilta-Cel Consistent In Earlier Myeloma, Longer-Term Results

Dec 13 2021

uniQure/CSL’s EtranaDez Could Take Lead Position In Hemophilia B Gene Therapy Market

Dec 09 2021

Multiple Myeloma Bispecifics Vie For Leadership Based On Safety, Combinability

Dec 15 2021

US FDA’s 2022 User Fee Calendar At A Glance

Feb 01 2022

Keeping Track Of Withdrawals: Libtayo, Parsaclisib Applications Pulled Due To Postmarketing Issues

Jan 28 2022

Related Companies

Immunocore, Ltd.

Genentech, Inc.

Amgen, Inc.

Roche Holding AG

Johnson & Johnson

Genmab A/S

GSK plc

Bristol Myers Squibb Company

Legend Biotech Corp.

Novartis AG

BioMarin Pharmaceutical Inc.

Genetix Biotherapeutics

uniQure N.V.

Atara Biotherapeutics, Inc.

Gamida Cell Ltd.

Akeso Inc.

Sino Biopharmaceutical Limited

Eli Lilly and Company

Innovent Biologics, Inc.

Junshi Biosciences/Immorna Joint Venture

Coherus Oncology, Inc.

Merck & Co., Inc.

CTI BioPharma Corp.

HUTCHMED (China) Limited

Spectrum Pharmaceuticals, Inc.

Allarity Therapeutics A/S

Mirati Therapeutics, Inc.

Additional Topics

United States Drug Review Regulation Pink Sheet Perspectives US FDA Performance Tracker BioPharmaceutical

More from Pink Sheet Perspectives

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window